Influenza and acute myocardial infarction

Journal of Infectious Diseases

Volumn 203, Issue 12, 2011, Pages 1701-1704

  Finelli, Lyn ^a   Chaves, Sandra S ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE;

ACUTE HEART INFARCTION; ANTIBODY TITER; ATHEROSCLEROSIS; ATTRIBUTABLE RISK; CAUSE OF DEATH; CLIMATE; DISEASE ASSOCIATION; EDITORIAL; GEOGRAPHIC DISTRIBUTION; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFLUENZA; MORTALITY; PATHOPHYSIOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SEASONAL VARIATION;

CLIMATE; ENGLAND; HOSPITALIZATION; HUMANS; INFLUENZA, HUMAN; MYOCARDIAL INFARCTION; POISSON DISTRIBUTION; RISK FACTORS; WALES;

EID: 79957469036     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir175     Document Type: Editorial

References (45)

1. Collins SD. Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Pub Health Rep 1932; 47:2159-79.
2. Reichert TA, Simonsen L, Sharma A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol 2004; 160:492-502.
3. Schneider A, Panagiotakos D, Picciotto S, et al. AIRGENE Study Group. Air temperature and inflammatory responses in myocardial infarction survivors. Epidemiology 2008; 19:391-400.
4. Donaldson GC, Keatinge WR. Excess winter mortality: influenza or cold stress? BMJ 2002; 324:89-90.
5. Wong CM, Chan KP, Hedley AJ, Peiris JS. Influenza-associated mortality in Hong Kong. Clin Infect Dis 2004; 39:1611-7. (Pubitemid 39578534)
6. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86. (Pubitemid 36068705)
7. Fleming DM, Cross KW, Pannell RS. Influenza and its relationship to circulatory disorders. Epidemiol Infect 2005; 133:255-62. (Pubitemid 40439305)
8. Fleming DM. The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. Commun Dis Public Health 2000; 3:32-8.
9. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997; 87:1944-50. (Pubitemid 28055910)
10. Barker WH, Mullooly JP. A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol 1982; 115:479-80.
11. Tillett HE, Nicholas S, Watson JM. Unusual pattern of influenza mortality in 1989/90. Lancet 1991; 338:1590-1.
12. Centers for Disease Control and Prevention. Guidance for clinicians on the use of rapid influenza diagnostic tests for the 2010-2011 influenza season. http://www.cdc.gov/flu/professionals/diagnosis/clinician-guidance-ridt. htm#table2. Accessed 15 February 2011.
13. Neuzil KM, Reed GW, Mitchel EF Jr., Griffin MR. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 1999; 281:901-7. (Pubitemid 29124633)
14. Madjid M, Miller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J 2007; 28:1205-10. (Pubitemid 47343835)
15. Warren-Gash C, Bhaskaran K, Hayward A, et al. Circulating influenza virus, climatic factors and acute myocardial infarction: a time series study in England and Wales and Hong Kong. J Infect Dis 2011. doi: 10.1093/infdis/JIR171.
16. Crowcroft NS, Cutts F, Zambon MC. Respiratory syncytial virus: an underestimated cause of respiratory infection, with prospects for a vaccine. Commun Dis Public Health 1999; 4:234-41.
17. Zambon MC, Stockton J, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 2001; 358:1410-6. (Pubitemid 33055743)
18. Stockton J, Stephenson I, Fleming D, Zambon M. Human metapneumovirus as a cause of community-acquired respiratory illness. Emerg Infect Dis 2002; 8:897-901. (Pubitemid 35000805)
19. Robertson L, Caley JP, Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet 1958; 2:233-6.
20. Bisno AL, Griffin JP, Van Epps KA, Niell HB, Rytel MW. Pneumonia and Hong Kong influenza: a prospective study of the 1968-1969 epidemic. Am J Med Sci 1971; 261:251-63.
21. Eickhoff TC, Sherman IL, Serfling RE. Observations on excess mortality associated with epidemic influenza. JAMA 1961; 176:776-82.
22. Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 1998; 351:1467-71. (Pubitemid 28227037)
23. Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984; 53:481-2. (Pubitemid 14188815)
24. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351:2611-8. (Pubitemid 39628582)
25. Mattila KJ. Viral and bacterial infections in patients with acute myocardial infarction. J Intern Med 1989; 225:293-6. (Pubitemid 19124824)
26. Pesonen E, Andsberg E, Grubb A, et al. Elevated infection parameters and infection symptoms predict an acute coronary event. Ther Adv Cardiovasc Dis 2008; 2:419-24.
27. Guan XR, Li X, Xin XM, et al. Influenza virus infection and risk of acute myocardial infarction. Inflammation 2008; 31:266-72.
28. Swerdlow DL, Roper MH, Morgan J, et al. Smallpox Vaccine Cardiac Adverse Events Working Group. Ischemic cardiac events during the Department of Health and Human Services Smallpox Vaccination Program, 2003. Clin Infect Dis 2008; 46(Suppl 3):S234-41.
29. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104:365-72. (Pubitemid 32666962)
30. Ison MG, Campbell V, Rembold C, Dent J, Hayden FG. Cardiac findings during uncomplicated acute influenza in ambulatory adults. Clin Infect Dis 2005; 40:415-22. (Pubitemid 40216510)
31. American Heart Association. Heart disease and stroke statistics: 2010 update at a glance. http://www.americanheart.rg/downloadable/heart/ 1265665152970DS-3241%20HeartStrokeUpdate-2010.pdf. Accessed 8 February 2011.
32. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59:1-62.
33. Ciszewski A, Bilinska ZT, Brydak LB, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 2008; 29:1350-8. (Pubitemid 351806477)
34. Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B. Flu Vaccination in Acute Coronary Syndromes and Planned Percutaneous Coronary Interventions (FLUVACS) study. Eur Heart J 2004; 25:25-31. (Pubitemid 38055589)
35. Warren-Gash C, Smeeth L, Hayward A. Influenza and myocardial infarction. Expert Rev Cardiovasc Ther 2010; 8:143-6.
36. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348:1322-32. (Pubitemid 36384099)
37. Jackson L, Yu O, Heckbert SR, et al. Vaccine Safety Datalink Study Group. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002; 156:634-40.
38. Heffelfinger J, Heckbert SR, Psaty BM, et al. Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin 2006; 2:161-6. (Pubitemid 44422482)
39. Naghavi M, Barlas Z, Siaday S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102:3039-45.
40. Siscovick DS, Raghunathan TE, Lin D, et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000; 152:674-7.
41. Lavallee P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002; 33:513-8. (Pubitemid 34123398)
42. Centers for Disease Control and Prevention. Antiviral agents for the treatment and chemoprophylaxis of influenza - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Surveill Summ 2011; 60:1-28.
43. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000; 283:1016-24. (Pubitemid 30112215)
44. Kaiser L, Wat C, Mills T, et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003; 163:1667-72. (Pubitemid 36898954)
45. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007; 45: 1568-75. (Pubitemid 351411840)